ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Celyad Oncology SA

Celyad Oncology SA (CYAD)

0.33
0.01
(3.13%)
Closed April 23 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.33
Bid
0.313
Ask
0.34
Volume
19,412
0.31 Day's Range 0.339
0.2975 52 Week Range 1.28
Market Cap
Previous Close
0.32
Open
0.31
Last Trade
25
@
0.33
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
18,066
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-1.62
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wavre, Walloon Brabant, Bel
Founded
1970
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.32 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.2975 € to 1.28 €.

Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is 13.67 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -1.62.

CYAD Latest News

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

Celyad Oncology reports third quarter 2023 financial results and recent business highlights

Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...

Celyad Oncology announces the termination of its American Depository Receipt program

MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces that Citibank, N.A., as depositary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0095-2.798232695140.33950.33950.3055105610.33435119DE
4-0.02-5.714285714290.350.3750.2975160130.34062441DE
12-0.06-15.38461538460.390.470.2975180660.37132073DE
26-0.344-51.03857566770.6740.70.2975357270.43138056DE
52-0.31-48.43750.641.280.2975321550.58613921DE
156-5.17-945.56.020.2975420792.20214109DE
260-17.95-98.194748358918.2818.980.2975445705.278544DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
MTCMMTec Inc
$ 2.24
(43.59%)
6.07M
OPRTOportun Financial Corporation
$ 3.16
(40.44%)
11.71M
SHIMShimmick Corporation
$ 3.05
(35.56%)
1.19M
HKITHitek Global Inc
$ 1.35
(32.35%)
411.78k
ABEOAbeona Therapeutics Inc
$ 3.39
(-53.94%)
5.51M
GWAVGreenwave Technology Solutions Inc
$ 0.0696
(-44.89%)
37.05M
LICNLichen China Limited
$ 0.56
(-42.19%)
6.61M
MLECMoolec Science SA
$ 1.71
(-30.77%)
3.16M
VAXXVaxxinity Inc
$ 0.1971
(-26.89%)
2.11M
CYNCYNGN Inc
$ 0.113
(-6.61%)
326.58M
PEGYPineapple Energy Inc
$ 0.0561
(22.49%)
185.74M
SQQQProShares UltraPro Short QQQ
$ 11.91
(-4.49%)
139.15M
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
TSLATesla Inc
$ 144.68
(1.85%)
124.55M

Discussion

View Full Feed
Split T Split T 3 minutes ago
Since the options are already showing the $82.50 at $1.75 and the $85.00 at $0.88 I believe my target is possible tomorrow. No advice, just looking at the possibilities from being a retail investor like the majority of you.



COOP Options
May 17, 2024
COOP
janice shell janice shell 3 minutes ago
What a hoot!!
JOHNNIEBG JOHNNIEBG 3 minutes ago
All your amazing profit and 3 bucks might get you a cup of coffee!!! Keep on enjoying the fake life you are living!!!
DJT
RainMaker2213 RainMaker2213 3 minutes ago
https://www.cnbc.com/amp/2024/04/23/despite-earnings-miss-nucor-ceo-is-confident-this-year-will-be-a-success.html
LBRMF
Ryan8 Ryan8 3 minutes ago
You will soon Learn

How is the weather in Frankfurt
DSCR
DailyX DailyX 3 minutes ago
Moonward tommorrow thanks shorts for the rocket this week!.!.!.!
TSLA
PEMBROKE1 PEMBROKE1 4 minutes ago
https://www.otcmarkets.com/otcapi/company/financial-report/397891/content
SIRC
ChannelTrader ChannelTrader 4 minutes ago
Do it !
XenaLives XenaLives 5 minutes ago
color.com mentioned in previous archive...

A little google yields this history:

ITEC: Color.com Web Site Now Offering Products and Training

Monday, October 08, 2001
Press release from the issuing company

SAN DIEGO, October 4, 2001
DFCO
XenaLives XenaLives 5 minutes ago
color.com mentioned in previous archive...

A little google yields this history:

ITEC: Color.com Web Site Now Offering Products and Training

Monday, October 08, 2001
Press release from the issuing company

SAN DIEGO, October 4, 2001
DFCO
wiwineguy wiwineguy 5 minutes ago
I hate Trump too. Again best of luck to you and all here just trying to beat the system that's slanted against the common man.
TGLO
janice shell janice shell 5 minutes ago
The first video still doesn't work...
Toofuzzy Toofuzzy 5 minutes ago
Deleated
PLUG
janice shell janice shell 5 minutes ago
Those people are scary. They say things that make no sense at all, and most of them aren't bothered by it.

(Your first video doesn't work.)
1vman 1vman 6 minutes ago
***** HYMC ( Hyturd ) needs to fire its promotional awareness campaign manager asap

ENOUGH SAID
HYMC
fuagf fuagf 6 minutes ago
Agree. The Good Liars are very good interviewers.

https://twitter.com/TheGoodLiars/status/1782599938095939689?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

And new to me. And yep, you video is worth watching to the end.
Toofuzzy Toofuzzy 6 minutes ago
That is good to hear. And by the end of the year they will cover 100% of their needs ( supposedly )

I.have been wondering for a long time how much they were buying from suppliers and what % they would be able to produce.

Of course now with the new supply , the price of
PLUG
DailyX DailyX 6 minutes ago
This is pointed straight up! After hours! Wait tell the bears cover or some may get a margin call. Looking forward to getting into the $180 channel soon.
TSLA
wiwineguy wiwineguy 7 minutes ago
You're right. As a person who made millions on the market betting against others, because that's really what the market is, betting against the masses. You are entitled to take what is given you. I would have done the same. My sincere apologies Chen for my caustic attack on you . Best of luck to
TGLO
XenaLives XenaLives 7 minutes ago
NOTHING HAS CHANGED !!!!

A DFCO history lesson:



Dalrada Financial Reports Second Quarter Results
Wednesday February 22, 9:20 am ET
- $17.8 Million Revenues; $3.3 Million Net Profit -


SAN DIEGO, Feb. 22 /PRNewswire-Fir
DFCO
Ga-Pro Ga-Pro 7 minutes ago
Or the the price is down do to continued
Dilution

CLNV SECURITY DETAILS
Share Structure

Market Cap Market Cap
15,270,639
04/22/2024
Authorized Shares
2,000,000,000
04/12/2024
Outstanding Shares
695,701,083
CLNV DTC
janice shell janice shell 8 minutes ago
The whole article is howlingly funny!
Running Wild Running Wild 8 minutes ago
Another mojo meltdown.

Heeeeeeeeee--larious!

DJT
XenaLives XenaLives 8 minutes ago
NOTHING HAS CHANGED !!!!

A DFCO history lesson:



Dalrada Financial Reports Second Quarter Results
Wednesday February 22, 9:20 am ET
- $17.8 Million Revenues; $3.3 Million Net Profit -


SAN DIEGO, Feb. 22 /PRNewswire-Fi
DFCO
staynafloat staynafloat 8 minutes ago
Yeah I kind of got blindsided by this one like many 😖
Win some lose some ........... lol this one really sucked for some reason.
DCFCQ

Your Recent History

Delayed Upgrade Clock